1. Home
  2. JAGX vs RELI Comparison

JAGX vs RELI Comparison

Compare JAGX & RELI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • RELI
  • Stock Information
  • Founded
  • JAGX 2013
  • RELI 2013
  • Country
  • JAGX United States
  • RELI United States
  • Employees
  • JAGX N/A
  • RELI N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • RELI Specialty Insurers
  • Sector
  • JAGX Health Care
  • RELI Finance
  • Exchange
  • JAGX Nasdaq
  • RELI Nasdaq
  • Market Cap
  • JAGX 3.5M
  • RELI 3.5M
  • IPO Year
  • JAGX N/A
  • RELI N/A
  • Fundamental
  • Price
  • JAGX $2.70
  • RELI $1.50
  • Analyst Decision
  • JAGX Strong Buy
  • RELI
  • Analyst Count
  • JAGX 1
  • RELI 0
  • Target Price
  • JAGX $60.00
  • RELI N/A
  • AVG Volume (30 Days)
  • JAGX 86.0K
  • RELI 3.7M
  • Earning Date
  • JAGX 08-12-2025
  • RELI 07-24-2025
  • Dividend Yield
  • JAGX N/A
  • RELI N/A
  • EPS Growth
  • JAGX N/A
  • RELI N/A
  • EPS
  • JAGX N/A
  • RELI N/A
  • Revenue
  • JAGX $11,552,000.00
  • RELI $14,208,143.00
  • Revenue This Year
  • JAGX $22.41
  • RELI N/A
  • Revenue Next Year
  • JAGX $30.00
  • RELI N/A
  • P/E Ratio
  • JAGX N/A
  • RELI N/A
  • Revenue Growth
  • JAGX 13.93
  • RELI 2.40
  • 52 Week Low
  • JAGX $2.43
  • RELI $0.97
  • 52 Week High
  • JAGX $110.75
  • RELI $5.11
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 33.71
  • RELI 45.59
  • Support Level
  • JAGX $2.53
  • RELI $1.52
  • Resistance Level
  • JAGX $2.65
  • RELI $1.74
  • Average True Range (ATR)
  • JAGX 0.18
  • RELI 0.25
  • MACD
  • JAGX 0.14
  • RELI -0.08
  • Stochastic Oscillator
  • JAGX 31.03
  • RELI 5.98

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About RELI Reliance Global Group Inc.

Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing acquisition strategies, initially and focused on wholesale and retail insurance agencies. Its primary strategies is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.

Share on Social Networks: